Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ODT

Odonate Therapeutics (ODT)

Odonate Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ODT
FechaHoraFuenteTítuloSímboloCompañía
10/02/202211:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ODTOdonate Therapeutics Inc
07/02/202208:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ODTOdonate Therapeutics Inc
31/01/202205:14Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ODTOdonate Therapeutics Inc
26/01/202208:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ODTOdonate Therapeutics Inc
26/01/202208:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ODTOdonate Therapeutics Inc
25/01/202216:31Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ODTOdonate Therapeutics Inc
07/01/202208:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ODTOdonate Therapeutics Inc
07/01/202208:00Business WireOdonate Announces Expected Delisting of Its StockNASDAQ:ODTOdonate Therapeutics Inc
10/12/202117:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ODTOdonate Therapeutics Inc
22/11/202110:09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ODTOdonate Therapeutics Inc
17/11/202106:45Business WireOdonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase PlanNASDAQ:ODTOdonate Therapeutics Inc
10/11/202116:15Business WireOdonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021NASDAQ:ODTOdonate Therapeutics Inc
10/11/202116:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ODTOdonate Therapeutics Inc
08/09/202106:00GlobeNewswire Inc.SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the FirmNASDAQ:ODTOdonate Therapeutics Inc
27/07/202107:30Business WireOdonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021NASDAQ:ODTOdonate Therapeutics Inc
02/07/202115:07Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ODTOdonate Therapeutics Inc
01/06/202115:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ODTOdonate Therapeutics Inc
14/05/202107:30Business WireOdonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021NASDAQ:ODTOdonate Therapeutics Inc
12/04/202107:02Edgar (US Regulatory)Schedule 13gNASDAQ:ODTOdonate Therapeutics Inc
22/03/202107:00Business WireOdonate Therapeutics Announces Discontinuation of Development of TesetaxelNASDAQ:ODTOdonate Therapeutics Inc
23/02/202107:30Business WireOdonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020NASDAQ:ODTOdonate Therapeutics Inc
23/02/202107:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ODTOdonate Therapeutics Inc
23/02/202106:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ODTOdonate Therapeutics Inc
11/12/202009:05Business WirePositive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at the 2020 S...NASDAQ:ODTOdonate Therapeutics Inc
07/12/202007:30Business WireOdonate Therapeutics Initiates Cohort 3 of CONTESSA TRIO to Evaluate Tesetaxel Monotherapy in Patients with Metastatic Breast...NASDAQ:ODTOdonate Therapeutics Inc
01/12/202007:30Business WireOdonate Therapeutics to Host Virtual Investor and Analyst Event on December 11, 2020NASDAQ:ODTOdonate Therapeutics Inc
27/11/202008:01Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ODTOdonate Therapeutics Inc
28/10/202007:30Business WireOdonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2020NASDAQ:ODTOdonate Therapeutics Inc
05/10/202007:30Business WireResults of CONTESSA, a Phase 3 Study of Tesetaxel in the Treatment of Patients with Metastatic Breast Cancer, to Be Presented...NASDAQ:ODTOdonate Therapeutics Inc
27/08/202018:45Business WireOdonate Therapeutics Announces Pricing of Public Offering of Shares of Common StockNASDAQ:ODTOdonate Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ODT